Advertisement
Screener

INTENSITY THERAPEUTICS, INC. (INTS) Form 10-Q: Quarterly report

INTENSITY THERAPEUTICS, INC. Form 10-Q: Quarterly report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-08-11: Form 10-Q; Period of report 2026-06-30; Description 10-Q; Document intensity-20260630.htm.
  • 2026-05-07: Form 10-Q; Period of report 2026-03-31; Description 10-Q; Document intensity-20260331.htm.
  • 2025-11-06: Form 10-Q; Period of report 2025-09-30; Description 10-Q; Document intensity-20250930.htm.
  • 2025-08-07: Form 10-Q; Period of report 2025-06-30; Description 10-Q; Document intensity-20250630.htm.
FiledFormPeriod of reportDescriptionDocument
2026-08-1110-Q2026-06-3010-Qintensity-20260630.htm
2026-05-0710-Q2026-03-3110-Qintensity-20260331.htm
2025-11-0610-Q2025-09-3010-Qintensity-20250930.htm
2025-08-0710-Q2025-06-3010-Qintensity-20250630.htm
2025-05-1310-Q2025-03-3110-Qintensity-20250331.htm
2024-11-1310-Q2024-09-3010-Qintensity-20240930.htm
2024-08-0810-Q2024-06-3010-Qintensity-20240630.htm
2024-05-0910-Q2024-03-3110-Qintensity-20240331.htm
2023-11-1310-Q2023-09-30QUARTERLY REPORTf10q0923_intensity.htm
2023-08-1410-Q2023-06-30QUARTERLY REPORTf10q0623_intensity.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Pluri Inc. (PLUR)$0.014B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Passage BIO, Inc. (PASG)United States$0.015B-0.43
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
BioCardia, Inc. (BCDA)United States$0.016B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37